Company profile: IBL International
1.1 - Company Overview
Company description
- Provider of immunoassays and antibodies/in-vitro diagnostic assays for research, clinical, and specialty laboratories; develops, manufactures, and distributes assays focused on special and rare indications in endocrinology, neonatal screening, and the diagnosis of stress parameters and steroid hormones.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to IBL International
Stilla Technologies
HQ: France
Website
- Description: Provider of digital PCR solutions to accelerate next-generation genetic testing, including the Nio System, an all-in-one 7-color, continuous-loading instrument for high-throughput analysis; the naica System, a multiplex dPCR platform with up to six fluorescent channels; ready-to-use digital PCR kits and assays; chips and reagents; and analysis software for image analysis and data export.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Stilla Technologies company profile →
Alderys
HQ: France
Website
- Description: Provider of innovative biological engineering approaches to produce chemical compounds of economic interest from renewable plant resources, including nutrients via rectified biosynthetic routes, targeting convenience chemicals, cosmetics, and animal nutrition markets, with environmentally respectful industrial technological solutions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Alderys company profile →
Stratec
HQ: Germany
Website
- Description: Provider of lab automation solutions and automated analyzer systems for IVD, clinical diagnostics, biotechnology, and life science sectors, offering laboratory data management and molecular diagnostic sample preparation and stabilization.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Stratec company profile →
Repligen
HQ: United States
Website
- Description: Provider of consumable bioprocessing products and systems for manufacturing biological drugs, including KrosFlo TFF systems for ultrafiltration, diafiltration and microfiltration; XCell ATF cell-retention systems, available in single-use or stainless steel formats; NGL COVID-19 spike protein affinity resin; CTech FlowVPX in-line spectrophotometry for GMP testing; ProConnex single-use flow paths; and fluid storage and transfer solutions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Repligen company profile →
Multi Channel Systems
HQ: Germany
Website
- Description: Provider of precise electrophysiology measuring instrumentation and software for research groups at universities, including microelectrode arrays (Mesh MEA) and systems combining laser-based optoporation with MEAs for intracellular action potential recordings in cardiac monolayers and organoids, plus data acquisition, analysis and screening tools (Multi Channel Suite, Multiwell-Screen, CMOS-MEA-Control, Beta-Screen Experimenter).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Multi Channel Systems company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for IBL International
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to IBL International
2.2 - Growth funds investing in similar companies to IBL International
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for IBL International
4.2 - Public trading comparable groups for IBL International
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →